Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The China healthcare cold chain logistics market was valued at USD 3.99 Billion in 2025 and is expected to grow at a CAGR of 8.90%, reaching USD 9.36 Billion by 2035. The expanding biopharmaceutical manufacturing, stringent quality regulations, and increased vaccine distribution are driving market growth, supported by infrastructure modernization and advanced temperature-controlled storage technologies.
Base Year
Historical Period
Forecast Period
Government-backed infrastructure expansion and rising biologics demand are positioning China as a leading hub for pharmaceutical cold chain logistics.
Advanced IoT-enabled monitoring and temperature-control technologies are reshaping China’s logistics landscape toward precision-driven and compliant pharmaceutical transport.
Investments from global players like Cold Chain Technologies and DHL Supply Chain highlight China’s strategic role in APAC cold chain modernization.
Compound Annual Growth Rate
8.9%
Value in USD Billion
2026-2035
*this image is indicative*
The market is growing robustly due to the expanding pharmaceutical and biotechnology sectors. Rising vaccine production, temperature-sensitive biologics, and regulatory standards on product safety are fueling investments in cold chain infrastructure. Technological advancements in temperature monitoring and transportation systems enhance efficiency and reliability. Moreover, government initiatives supporting healthcare innovation and logistics modernization further strengthen the ecosystem, positioning China as a leading hub for secure and efficient healthcare cold chain distribution. The market is anticipated to grow at a CAGR of 8.90% during the forecast period of 2026-2035.
Expansion of Cold Chain Infrastructure Supporting Pharmaceutical Logistics Growth in China
The market is being driven by expanding cold storage infrastructure and regulatory support. In 2025, the Chinese government introduced subsidies to modernize pharmaceutical logistics networks, resulting in an 8% year-on-year increase in cold storage capacity. Growing demand for temperature-sensitive biologics, vaccines, and cell-based therapies has further boosted investments from key players like Cold Chain Technologies and DHL Supply Chain. This infrastructural expansion enhances temperature integrity, ensuring quality and safety in drug distribution across China’s rapidly growing biopharmaceutical sector.
Major market trends highlight China’s shift toward smart, sustainable, and technology-driven pharmaceutical logistics solutions.
Increasing Investments in Advanced Temperature-Control Technologies to Boost China Healthcare Cold Chain Logistics Market Demand
A significant trend in China’s cold chain logistics market is the adoption of advanced temperature-control systems and IoT-enabled monitoring. Companies are deploying real-time data tracking, predictive analytics, and reusable thermal packaging to ensure compliance with Good Distribution Practices (GDP). The 2025 expansion of Cold Chain Technologies’ APAC hubs, including China, reflects rising demand for energy-efficient, high-performance systems to support biologics and mRNA vaccines. This trend demonstrates China’s transition from conventional logistics to smart, sustainable, and precision-based pharmaceutical cold chain operations.
Biopharmaceuticals to Lead the Segment by Product Type
The biopharmaceutical segment held the dominant position in the market, accounting for approximately 49% of total revenue during the historical period. This strong performance was driven by the surging demand for temperature-sensitive vaccines, biologics, and advanced therapeutics, coupled with expanding biopharmaceutical manufacturing capacities. Continuous advancements in cold storage infrastructure and logistics technology further supported the segment’s growth and reinforced its leading share in the overall market.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Founded in 1971 and headquartered in Dublin, Ohio, USA, Cardinal Health is a global leader in healthcare distribution and logistics. The company offers advanced cold chain logistics solutions, ensuring the safe and compliant transport of temperature-sensitive pharmaceuticals and biologics. In China, Cardinal Health focuses on optimizing supply chain efficiency for biopharmaceutical companies through integrated distribution, regulatory compliance, and storage services tailored to the healthcare cold chain market.
Headquartered in Bonn, Germany, and established in 1969, DHL Group (DHL Supply Chain & Global Forwarding) is a leading global logistics provider specializing in healthcare cold chain management. The company offers end-to-end temperature-controlled logistics, warehousing, and last-mile delivery solutions across China. Its Life Sciences and Healthcare division supports pharmaceutical and biotechnology clients with certified facilities, real-time monitoring, and sustainable logistics operations.
Founded in 1907 and headquartered in Atlanta, Georgia, USA, UPS Healthcare provides specialized cold chain logistics solutions designed for the biopharmaceutical and medical device industries. In China, UPS operates advanced temperature-controlled facilities and employs smart monitoring systems to ensure shipment integrity. Its portfolio includes cold storage, distribution, and express delivery services, enabling safe handling of critical healthcare products across the Chinese life sciences supply chain.
Established in 1973 and based in Memphis, Tennessee, USA, FedEx Logistics delivers global cold chain transportation and supply chain management solutions for the healthcare industry. In China, it provides integrated cold storage, real-time tracking, and express shipping services tailored for pharmaceuticals, vaccines, and biologics. Through its FedEx Cold Chain Solutions, the company ensures temperature integrity and regulatory compliance throughout cross-border and domestic healthcare logistics operations.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other players in the market include CEVA Logistics, Agility Logistics, Lineage Logistics, Nippon Express, SF Express, and AirBridgeCargo Airlines.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Service Type
Market Breakup by Product Type
Market Breakup by Temperature Range
Market Breakup by Mode of Transportation
Market Breakup by End User
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Service Type |
|
| Breakup by Product Type |
|
| Breakup by Temperature Range |
|
| Breakup by Mode of Transportation |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share